Page last updated: 2024-08-24

camonagrel and thromboxane b2

camonagrel has been researched along with thromboxane b2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De La Cruz, JP; García Campos, J; Moreno, A; Ruiz-Ruiz, MI; Sánchez de la Cuesta, F1
Arrebola, MM; De La Cruz, JP; Escalante, R; Guerrero, A; Sánchez de la Cuesta, F; Villalobos, MA1

Other Studies

2 other study(ies) available for camonagrel and thromboxane b2

ArticleYear
Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.
    European journal of pharmacology, 1998, May-29, Volume: 350, Issue:1

    Topics: Animals; Blood Cell Count; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Fibrinolysis; Imidazoles; Indans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Retinal Neovascularization; Streptozocin; Thromboxane B2; Thromboxane-A Synthase

1998
Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction.
    Pharmacology, 2003, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Animals; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Indans; Male; Middle Aged; Platelet Aggregation; Prostaglandins; Prostaglandins E; Rabbits; Thrombosis; Thromboxane B2; Thromboxane-A Synthase; Tunica Intima

2003